S Morandi
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Hemoglobinopathies and Related Disorders
Papers in
- Hematology 10
- Chronic Myeloid Leukemia Treatments 4
- Multiple Myeloma Research and Treatments 3
- Acute Myeloid Leukemia Research 2
-
- Acute Lymphoblastic Leukemia research 8
- Co-authors
- Giovanni Barosi (8 shared papers)Mario Cazzola (5 shared papers)Mario Stefanelli (4 shared papers)Giampaolo Merlini (3 shared papers)Carlomaurizio Montecucco (2 shared papers)R Bettini (1 shared paper)Luigi Cavanna (1 shared paper)Carla Pieresca (1 shared paper)
- Journals
- Blood (3 papers)The Hematology Journal (2 papers)British Journal of Haematology (1 paper)Annals of the Rheumatic Diseases (1 paper)International Journal of Oncology (1 paper)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
S Morandi
24 papers receiving 326 citations
Peers
Comparison fields: 5 of 41
- Hematology 176
- Genetics 153
- Pathology and Forensic Medicine 89
- Public Health, Environmental and Occupational Health 82
- Nephrology 16
Countries citing papers authored by S Morandi
This map shows the geographic impact of S Morandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Morandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Morandi more than expected).
Fields of papers citing papers by S Morandi
This network shows the impact of papers produced by S Morandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Morandi. The network helps show where S Morandi may publish in the future.
Co-authors
The 25 scholars most cited alongside S Morandi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 92 | |
| 2 | 1978 | 34 | |
| 3 | 2004 | 26 | |
| 4 | 2001 | 25 | |
| 5 | 2001 | 24 | |
| 6 | 1979 | 18 | |
| 7 | Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study. | 1999 | 15 |
| 8 | 2000 | 14 | |
| 9 | 1996 | 13 | |
| 10 | 1994 | 13 | |
| 11 | 2008 | 11 | |
| 12 | 1976 | 11 | |
| 13 | An approach by means of mathematical models to the analysis of ferrokinetic data obtained by liquid scintillation counting of 59Fe. | 1976 | 10 |
| 14 | Mitoxantrone alone or in combination chemotherapy (VeMP) as second-line treatment in relapsed or refractory poor-prognosis non-Hodgkin's lymphoma. A report of the Non-Hodgkin's Lymphoma Co-operative Study Group (NHLCSG). | 1992 | 9 |
| 15 | 1988 | 8 | |
| 16 | 1978 | 7 | |
| 17 | 1987 | 5 | |
| 18 | 1978 | 4 | |
| 19 | Cutaneous flagellate pigmentation by bleomycin. | 2000 | 3 |
| 20 | Role of anthracycline dose intensity in adult Philadelphia chromosome/BCR-ABL positive and negative B-lineage acute lymphoblastic leukemia | 1999 | 2 |
About S Morandi
S Morandi is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Genetics, Molecular Biology and Pathology and Forensic Medicine, having authored 24 papers that have together received 348 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Multiple Myeloma Research and Treatments (3 papers), Cancer Treatment and Pharmacology (2 papers), Acute Myeloid Leukemia Research (2 papers) and Hemoglobinopathies and Related Disorders (2 papers). The work is most often cited by research in Hematology (176 citations), Genetics (153 citations), Pathology and Forensic Medicine (89 citations), Public Health, Environmental and Occupational Health (82 citations) and Nephrology (16 citations). S Morandi has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Giovanni Barosi, Mario Cazzola, Mario Stefanelli, Giampaolo Merlini, Carlomaurizio Montecucco, R Bettini, Luigi Cavanna, Carla Pieresca, Daniele Bertoloni and Giovanni Grignani. Their work appears in journals such as Blood, The Hematology Journal, British Journal of Haematology, Annals of the Rheumatic Diseases and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.